AJAY SHESHADRI to Neoplasms
This is a "connection" page, showing publications AJAY SHESHADRI has written about Neoplasms.
Connection Strength
0.979
-
Coronavirus Disease-2019 in the Immunocompromised Host. Infect Dis Clin North Am. 2024 Mar; 38(1):213-228.
Score: 0.146
-
Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med. 2023 09; 12(17):17753-17765.
Score: 0.140
-
Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease. Curr Opin Pulm Med. 2023 07 01; 29(4):248-255.
Score: 0.138
-
Pulmonary Toxicities of Immunotherapy. Adv Exp Med Biol. 2021; 1342:357-375.
Score: 0.117
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2020; 1244:255-269.
Score: 0.109
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2018; 995:131-149.
Score: 0.095
-
Toxicity in the era of immune checkpoint inhibitor therapy. Front Immunol. 2024; 15:1447021.
Score: 0.038
-
Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
Score: 0.036
-
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes. 2023 05 26; 7(1):48.
Score: 0.035
-
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. Int J Mol Sci. 2023 Apr 24; 24(9).
Score: 0.034
-
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
Score: 0.033
-
Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med. 2020 02; 133(2):240-244.
Score: 0.027
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.024
-
Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy. Clin Chest Med. 2024 Jun; 45(2):325-337.
Score: 0.009